Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia
AssigneeChelsea Therapeutics, Inc.
InventorsMichael J. Roberts, Simon Pedder
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of treating fibromyalgia or other diseases or conditions causing widespread pain and/or fatigue. In particular, the invention provides pharmaceutical compositions comprising droxidopa alone, or in combination with one or more further active agents, that can be used in the inventive methods. The methods of treatment can comprise treating, preventing, reducing, or eliminating a variety of symptoms recognized as indicative of fibromyalgia, such as chronic pain, allodynia, hyperalgesia, fatigue, sleep disturbance, and depression.
Claims20
A method for reducing pain associated with fibromyalgia, the method comprising administering a therapeutically effective amount of droxidopa to a patient suffering from fibromyalgia.
Dependencies are inferred from the claim text.